Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for STRATA Skin Sciences (SSKN) over the last 13 years, with Q3 2025 value amounting to $2.2 million.

  • STRATA Skin Sciences' Cash from Financing Activities rose 1281.52% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 1387.01%. This contributed to the annual value of $1.9 million for FY2024, which is 7194.29% down from last year.
  • STRATA Skin Sciences' Cash from Financing Activities amounted to $2.2 million in Q3 2025, which was up 1281.52% from $1.9 million recorded in Q3 2024.
  • STRATA Skin Sciences' 5-year Cash from Financing Activities high stood at $7.0 million for Q2 2023, and its period low was -$500000.0 during Q4 2022.
  • Over the past 5 years, STRATA Skin Sciences' median Cash from Financing Activities value was $92000.0 (recorded in 2021), while the average stood at $1.5 million.
  • As far as peak fluctuations go, STRATA Skin Sciences' Cash from Financing Activities soared by 196826.92% in 2024, and later skyrocketed by 1281.52% in 2025.
  • Over the past 5 years, STRATA Skin Sciences' Cash from Financing Activities (Quarter) stood at $92000.0 in 2021, then crashed by 643.48% to -$500000.0 in 2022, then skyrocketed by 79.2% to -$104000.0 in 2023, then surged by 1968.27% to $1.9 million in 2024, then increased by 12.82% to $2.2 million in 2025.
  • Its Cash from Financing Activities was $2.2 million in Q3 2025, compared to $1.9 million in Q3 2024 and -$18000.0 in Q1 2024.